Using Artificial Intelligence to Advance DBS Treatment for Parkinson's
At Duke, researchers are using artificial intelligence to building an antomical brain map for each individual patient, which will allow more neurosurgeons to be able to offer deep brain stimulation treatments to people with Parkinson's disease.
Duke Neurosurgery Celebrates Match Day 2021
On March 19, Duke Neurosurgery Match Day by welcoming three outstanding new residents to our program.
Getting to know Annick Desjardins
Some people fall into their life’s work by serendipity or happenstance. Annick Desjardins, MD, FRCPC, is not one of those people.
Treating the whole person: Carolyn Keeler, DO
Celebrating Women’s History Month
Before Carolyn Keeler, DO, was a doctor, she was a dancer.
Parents of Children with Cancer Have Additional Worries During COVID
A survey of caregivers finds that most experienced instances of delayed care and other stresses.
Duke, Sampson rank at the top in NIH funding for 2020
The Duke Department of Neurosurgery has been ranked fourth for neurosurgery research funding from the National Institutes of Health (NIH) for 2020.
Recurrent GBM brain tumors with few mutations respond best to immunotherapy
The finding from a genetic analysis of tumors treated with Duke’s poliovirus therapy suggests a predictive biomarker for survival
Study looks at use of riluzole as an adjunct to surgery for degenerative cervical myelopathy
Neuroprotective drug may benefit patients with DCM
Degenerative cervical myelopathy (DCM) is the leading cause of spinal cord dysfunction among adults worldwide. This condition is characterized by stenosis, or compression of the cervical spinal cord and manifests in weakness and incoordination of both the upper and lower extremities. As patients age, osteoarthritis of the facet joints and ligaments makes this compression worse.